Researchers and (potential) entrepreneurs in the field of life sciences.
• How to start a biotech company
• How to find and choose the best startup incubators and accelerators
• The importance of Intellectual property and the role of technology transfer offices
• How to raise early stage seed investment
• How to choose the right partners (Venture Capital, Industry, Research, Associations, Public Authorities)
Raúl G. Saraiva is an associate at Apple Tree Partners (ATP), a life sciences venture capital firm focused on building research-driven transformative companies. He is also the head of operations at Aethon Therapeutics, a recent ATP-launched start-up that unites immune and targeted therapy to expand the power and promise of both approaches for fighting cancer. Prior to that, he was the investment manager for the therapeutics portfolio of Portugal Ventures, an institutional investor focusing on seed-stage financing of projects stemming from Raúl’s native Portugal.
His deal sheet includes investments such as CellmAbs Biopharmaceuticals, which develops glycan-targeting immunotherapies, and LiMM Therapeutics, a company drugging the neuronal activating pathways of innate lymphoid cells.
Raúl was a Fulbright Scholar to Johns Hopkins University, where he was awarded his PhD in molecular microbiology and immunology. He trained in biochemistry for his BSc and MSc at Universidade do Porto.
David Braga Malta is a Life Sciences Entrepreneur, Inventor and Investor, i.a. founded Cell2B, BoostPharma and LiMM Therapeutics. David is a Member of P-BIO since 2019.
David holds a PhD in Bioengineering from the MIT Portugal Program and a M.Sc. Degree in Biological Engineering, Instituto Superior Técnico, Portugal.
The session had nearly 50 participants